Skip to main content

Key Law and Policy Considerations for Clinical Bioinformaticians

  • Chapter
  • First Online:
Application of Clinical Bioinformatics

Part of the book series: Translational Bioinformatics ((TRBIO,volume 11))

  • 2441 Accesses

Abstract

This chapter describes five key areas in which clinical bioinformatics activities are regulated by law and policy. These are, namely, open-data requirements, consent practices, anonymization strategies, restrictions on cross-border data transfer, and prohibitions on genetic discrimination. The discussion draws on examples of norms that are currently in effect in North America, Europe, Asia, and Oceania in order to illustrate the ways in which positions on various specific questions can either mutually converge or deviate from one another around the globe. The tension that animates virtually all of the debates throughout this area, whether explicitly or through proxy issues, this chapter argues, is between the promotion of the interests of research participants—particularly in ensuring data privacy—on the one hand, and in establishing a landscape optimized to best promote medical research discoveries, on the other.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Each of these laws have been significantly amended since they were initially enacted.

  2. 2.

    In the common law and civil law traditions, respectively.

  3. 3.

    Namely, the Canadian Institutes of Health Research (CIHR); the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC).

  4. 4.

    Or any of various synonyms used, such as ‘identifying data’.

References

Download references

Disclosure Statement

Funding for this work was provided by the Canada Research Chair in Law and Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Phillips B.Sc., LL.B., B.C.L. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Phillips, M. (2016). Key Law and Policy Considerations for Clinical Bioinformaticians. In: Wang, X., Baumgartner, C., Shields, D., Deng, HW., Beckmann, J. (eds) Application of Clinical Bioinformatics. Translational Bioinformatics, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7543-4_14

Download citation

Publish with us

Policies and ethics